Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease

被引:0
|
作者
Carp, JM [1 ]
Onuma, E [1 ]
Das, K [1 ]
Gottlieb, AB [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT MED, ROBERT WOOD JOHNSON UNIV HOSP, NEW BRUNSWICK, NJ 08903 USA
来源
CUTIS | 1997年 / 60卷 / 03期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pyoderma gangrenosum is a destructive, ulcerative skin condition often associated with systemic illnesses such as inflammatory bowel disease, myelo-proliferative disorders, and the inflammatory arthritides. We present a patient with long-standing pyoderma gangrenosum associated with Crohn's disease. Multiple deep leg ulcerations were unresponsive over the course of several years to treatment with azathioprine, systemic corticosteroids, B-mercaptopurine, and dapsone. The patient was hospitalized and treated with a ten-day course of intravenous cyclosporine therapy followed by outpatient oral cyclosporine and showed significant improvement.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 50 条
  • [1] Treatment of Pyoderma Gangrenosum with Infliximab in Crohn's Disease
    Mark S. Sapienza
    Sidney Cohen
    Anthony J. Dimarino
    Digestive Diseases and Sciences, 2004, 49 : 1454 - 1457
  • [2] Treatment of pyoderma gangrenosum associated with Crohn's disease
    Ohmori, T
    Yamagiwa, A
    Nakamura, I
    Nishikawa, K
    Saniabadi, AR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (09): : 2101 - 2102
  • [3] Treatment of pyoderma gangrenosum with Infliximab in Crohn's disease
    Sapienza, MS
    Cohen, S
    DiMarino, AJ
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (09) : 1454 - 1457
  • [4] Cyclosporine A for the treatment of pyoderma gangrenosum
    Rowe, WA
    GASTROENTEROLOGY, 1999, 116 (04) : A807 - A807
  • [5] Ustekinumab for Treatment of Refractory Pyoderma Gangrenosum in a Crohn's Disease Patient
    Groudan, Kevin
    Singhania, Rohit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1032 - S1032
  • [6] Successful Treatment of Pyoderma Gangrenosum With Vedolizumab in a Crohn's Disease Patient
    Groudan, Kevin
    Gupta, Kamesh
    Chalhoub, Jean
    Singhania, Rohit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1184 - S1184
  • [7] Facial Pyoderma Gangrenosum in Crohn's Disease: Treatment Options and Outcomes
    Huang, Brian
    Melmed, Gil
    Wegge, Julia
    Shainsky, Karen
    Ippoliti, Andrew
    McGovern, Dermot
    Vasiliauskas, Eric
    Fleshner, Philip
    Dubinsky, Marla
    Targan, Stephan
    Shih, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S353 - S353
  • [8] Vedolizumab (Entyvio®) for the Treatment of Pyoderma Gangrenosum in a Crohn's Disease Patient
    Groudan, Kevin
    Gupta, Kamesh
    Singhania, Rohit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [9] Adalimumab Treatment for Peristomal Pyoderma Gangrenosum Associated with Crohn's Disease
    Alkhouri, Naim
    Hupertz, Vera
    Mahajan, Lori
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (06) : 803 - 806
  • [10] Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease
    Friedman, S
    Marion, JF
    Scherl, E
    Rubin, PH
    Present, DH
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (01) : 1 - 7